Subscribe for free to our flagship newsletter, CDR: This Week in Retail, for news and insights from the voice of retail pharmacy.

Skip to content

Camber launches generic Velcade

Bortezomib for injection is available in 3.5 mg strength, packaged in a single-dose vial.

PISCATAWAY, N.J. –Camber Pharmaceuticals is excited to announce the addition of bortezomib for injection.

Bortezomib for injection is a proteasome inhibitor indicated for:

• treatment of adult patients with multiple myeloma

• treatment of adult patients with mantle cell lymphoma

Bortezomib for injection is available in 3.5 mg strength, packaged in a single-dose vial.

Comments

Latest